Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 71.00%148.29M | 12.80%163.16M | 462.00%86.72M | 289.46%144.65M | -9.08%15.43M | -32.26%37.14M | -66.29%16.97M | -0.34%54.83M | 76.72%50.35M | -40.87%55.02M |
| Operating income | 71.00%148.29M | 12.80%163.16M | 462.00%86.72M | 289.46%144.65M | -9.08%15.43M | -32.26%37.14M | -66.29%16.97M | -0.34%54.83M | 76.72%50.35M | -40.87%55.02M |
| Cost of sales | -70.85%-141.97M | -22.38%-151.82M | -685.69%-83.1M | -323.00%-124.06M | 5.69%-10.58M | 38.98%-29.33M | 73.58%-11.21M | 6.04%-48.06M | -44.36%-42.45M | 45.72%-51.15M |
| Operating expenses | -70.85%-141.97M | -22.38%-151.82M | -685.69%-83.1M | -323.00%-124.06M | 5.69%-10.58M | 38.98%-29.33M | 73.58%-11.21M | 6.04%-48.06M | -44.36%-42.45M | 45.72%-51.15M |
| Gross profit | 74.40%6.32M | -44.90%11.34M | -25.40%3.62M | 163.53%20.58M | -15.69%4.85M | 15.46%7.81M | -27.15%5.76M | 75.12%6.77M | 965.50%7.9M | 421.38%3.86M |
| Selling expenses | 57.69%-473K | 2.84%-2.16M | 13.13%-1.12M | 52.05%-2.22M | -283.04%-1.29M | -278.10%-4.63M | 12.50%-336K | -20.71%-1.22M | 18.12%-384K | 75.32%-1.01M |
| Administrative expenses | 17.29%-13.08M | -6.07%-32.44M | -13.44%-15.81M | 14.42%-30.58M | -8.08%-13.94M | 3.25%-35.73M | 26.25%-12.9M | -3.53%-36.93M | 16.82%-17.49M | 46.52%-35.67M |
| Research and development expenses | 48.66%-211K | 30.57%-804K | 33.50%-411K | 65.94%-1.16M | 66.23%-618K | 1.13%-3.4M | -6.89%-1.83M | -209.26%-3.44M | -196.71%-1.71M | 68.77%-1.11M |
| Impairment and provision | -299.65%-3.97M | 112.56%774K | 137.74%1.99M | -141.64%-6.16M | -132.13%-5.26M | 165.33%14.79M | --16.38M | -116.16%-22.64M | ---- | ---10.47M |
| -Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---2.88M | ---- | ---- | ---- | ---- |
| -Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---6.57M | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -299.65%-3.97M | 112.56%774K | 137.74%1.99M | -125.41%-6.16M | -132.13%-5.26M | 207.08%24.24M | --16.38M | -116.16%-22.64M | ---- | ---10.47M |
| Special items of operating profit | 156.02%2.2M | -101.38%-982K | -105.44%-3.93M | 648.44%71.39M | 1,509.33%72.2M | -147.32%-13.02M | -3,149.40%-5.12M | 1,056.80%27.51M | -90.92%168K | 90.38%-2.88M |
| Operating profit | 41.21%-9.21M | -146.79%-24.26M | -128.00%-15.66M | 251.75%51.86M | 2,767.71%55.95M | -14.05%-34.17M | 116.95%1.95M | 36.63%-29.97M | 45.52%-11.51M | 55.16%-47.29M |
| Financing cost | -11.06%-13.87M | -73.91%-24.4M | -72.58%-12.49M | -0.11%-14.03M | 7.85%-7.24M | 53.20%-14.02M | -8.50%-7.85M | -26.00%-29.95M | 36.47%-7.24M | 4.37%-23.77M |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -83.12%134K |
| Earning before tax | 18.02%-23.08M | -228.66%-48.67M | -157.79%-28.15M | 178.49%37.83M | 925.66%48.71M | 19.57%-48.19M | 68.53%-5.9M | 15.52%-59.92M | 42.39%-18.75M | 45.25%-70.92M |
| Tax | -123.11%-589K | -136.17%-1.86M | 18,307.14%2.55M | 305.44%5.13M | -100.84%-14K | -86.84%-2.5M | 10,462.50%1.66M | -132.71%-1.34M | -260.00%-16K | 359.73%4.09M |
| After-tax profit from continuing operations | 7.56%-23.67M | -217.61%-50.52M | -152.57%-25.6M | 184.75%42.96M | 1,248.04%48.7M | 17.25%-50.69M | 77.39%-4.24M | 8.35%-61.25M | 42.32%-18.76M | 48.05%-66.84M |
| Earning after tax | 7.56%-23.67M | -217.61%-50.52M | -152.57%-25.6M | 184.75%42.96M | 1,248.04%48.7M | 17.25%-50.69M | 77.39%-4.24M | 8.35%-61.25M | 42.32%-18.76M | 48.05%-66.84M |
| Minority profit | -149.28%-865K | -42.86%-2.14M | 42.64%-347K | -129.28%-1.5M | -107.57%-605K | 163.51%5.12M | 982.79%7.99M | -612.29%-8.06M | 153.83%738K | 82.86%-1.13M |
| Profit attributable to shareholders | 9.72%-22.8M | -208.83%-48.38M | -151.22%-25.25M | 179.66%44.46M | 503.05%49.31M | -4.90%-55.81M | 37.27%-12.23M | 19.04%-53.2M | 37.42%-19.5M | 46.17%-65.7M |
| Basic earnings per share | 14.00%-0.0215 | -189.14%-0.0468 | -140.19%-0.025 | 174.47%0.0525 | 501.29%0.0622 | -2.92%-0.0705 | 39.45%-0.0155 | 25.38%-0.0685 | 42.47%-0.0256 | 57.42%-0.0918 |
| Diluted earnings per share | 14.00%-0.0215 | -189.14%-0.0468 | -142.96%-0.025 | 174.47%0.0525 | 475.48%0.0582 | -2.92%-0.0705 | 39.45%-0.0155 | 25.38%-0.0685 | 42.47%-0.0256 | 57.42%-0.0918 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unaudited opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Unite & Bai Chun (Hong Kong) Certified Public Accountants Limited | -- | Pak Chun Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.